Publicação em atas de evento científico
Substitutability between drugs, innovation and growth in the pharmaceutical industry
Felipa Sampayo (Mello-Sampayo, F. de.); Sofia Vale (Vale, S. de S.); Francisco Camões (Camões, F.);
10th EBES Conference Proceedings
Ano (publicação definitiva)
2013
Língua
Inglês
País
Turquia
Mais Informação
Web of Science®

N.º de citações: 1

(Última verificação: 2024-10-08 20:39)

Ver o registo na Web of Science®

Scopus

Esta publicação não está indexada na Scopus

Google Scholar

N.º de citações: 1

(Última verificação: 2024-10-07 02:04)

Ver o registo no Google Scholar

Abstract/Resumo
This paper establishes a relationship between the elasticity of demand for pharmaceutical intermediates and the growth rate for these intermediates variety. We build a model that contains two sectors, one final good sector producing treatments, and one intermediate goods sector producing a differentiated input used in the final treatment. The effects on the medicaments varieties' growth rate of the introduction of a fiscal instrument over pharmaceutical producers' profits are discussed. When the fiscal instrument is a tax over intermediate firms' profits, R&D by firms in the pharmaceutical goods sector results in positive growth provided there is enough substitutability among intermediates assured by a patent system. Otherwise, a subsidy over pharmaceutical firms' profits should be considered to generate positive growth of innovation in medicaments.
Agradecimentos/Acknowledgements
--
Palavras-chave
Monopolistic competition,Pharmaceutical industry,Fiscal policy
Registos de financiamentos
Referência de financiamento Entidade Financiadora
PTDC/EGE-ECO/104157/2000/ Fundação para a Ciência e a Tecnologia